ABCB1 and ovarian cancer: These results show that siRNA@PLGA NPs can efficiently suppress the function of P-glycoproteins in the MDR ovarian cancer cells and thus increase the accumulation of intracellular drugs, which is highly associated with potential tumor responsiveness to chemotherapeutics.